PX1 Research delivers fully verified, USA-manufactured TB-500 for high-precision laboratory experimentation. Every batch is supported by an independent Certificate of Analysis detailing high-performance liquid chromatography, mass spectrometry identification, and low-endotoxin compliance for preclinical protocols.
PX1 Research delivers fully verified, USA-manufactured TB-500 for high-precision laboratory experimentation. Every batch is supported by an independent Certificate of Analysis detailing high-performance liquid chromatography, mass spectrometry identification, and low-endotoxin compliance for preclinical protocols.
A valid USA TB-500 Certificate of Analysis (COA) provides independent analytical verification confirming peptide identity, chemical purity, and biosafety standards. Issued by an accredited ISO 17025 laboratory, a legitimate COA must feature lot-specific reverse-phase high-performance liquid chromatography (RP-HPLC) chromatograms displaying greater than 99% purity, electrospray ionization mass spectrometry (ESI-MS) validating exact molecular weight, and chromogenic Limulus Amebocyte Lysate (LAL) testing for endotoxin detection.
For principal investigators evaluating domestic suppliers, securing an authentic batch-specific COA is essential to prevent experimental confounders in cell culture and animal models. Unverified peptides may exhibit structural truncations, organic solvent carryover, or bacterial endotoxin levels that alter cellular responses, compromising research integrity. Reviewing verified analytical reports before acquisition ensures that experimental data regarding cell migration, tissue flexibility, and microvascular formation remain reproducible across study cohorts.
TB-500 is a synthetic peptide derived from the active domain of naturally occurring Thymosin Beta-4 (Tβ4). While full-length Thymosin Beta-4 comprises a 43-amino-acid sequence, TB-500 specifically incorporates the functional N-terminal fragment—frequently synthesized as the LKKTETQ hexapeptide sequence or related truncated analogues. This localized sequence retains the core bioactivity of the parent molecule while offering distinct structural stability for targeted laboratory research.
The molecular weight of TB-500 synthetic sequences generally falls between 889.0 Da and 4963.5 Da depending on whether the full 43-residue Tβ4 chain or the isolated active fragment is expressed. In research settings, the compound exhibits high solubility in aqueous buffer systems, allowing precise concentration titrations during *in vitro* assays. Laboratories investigating cellular mechanics utilize the TB-500 research peptide to isolate actin dynamics from broader hormonal signalling pathways.
In preclinical literature, TB-500 functions primarily as a G-actin sequestering peptide. By binding to monomeric G-actin in a 1:1 stoichiometric ratio, the peptide modulates actin filament polymerization dynamics within the cellular cytoskeleton. This mechanism is critical for regulating cell motility, allowing lamellipodia formation and cellular migration toward damaged tissue sites during experimental wound-healing models.
Additionally, preclinical studies suggest that TB-500 stimulates microvascular endothelial cell differentiation and accelerates tube formation in matrix assays. By upregulating matrix metalloproteinases (MMPs) and promoting vascular endothelial growth factor (VEGF) cascades, the peptide facilitates capillary sprouting. Researchers tracking blood-vessel formation and tissue perfusion evaluate these pathways to understand how structural matrix remodeling occurs during post-injury recovery phases.
Academic literature frequently highlights the role of TB-500 in promoting soft-tissue repair and muscle-fiber regeneration. In rodent models of skeletal muscle laceration and ischemic injury, researchers observed accelerated satellite cell activation and enhanced muscle precursor migration following peptide administration. These cellular actions correlate with reduced fibrotic scar deposition and improved structural alignment of newly synthesized muscle fibers.
Further *in vitro* and animal data indicate that TB-500 enhances tissue flexibility by regulating extracellular matrix (ECM) composition. The peptide suppresses hyper-inflammatory cytokine expression—such as TNF-alpha and IL-1 beta—while encouraging type I and type III collagen synthesis in balanced ratios. For detailed mechanistic breakdowns of these cellular interactions, scientists can consult our analytical review on the TB-500 mechanism of action.
Evaluating a TB-500 COA requires a detailed examination of reverse-phase high-performance liquid chromatography (RP-HPLC) spectra. High-grade research material must exhibit a single, sharp elution peak with minimal baseline drift, demonstrating chemical purity exceeding 98% or 99%. Secondary peaks represent synthesis failure sequences, truncated peptides, or residual protecting groups (such as TFA adducts), which can interfere with biological assays.
Mass spectrometry (ESI-MS or MALDI-TOF) provides the definitive identity check by confirming the exact mass-to-charge ratio ($m/z$) of the synthesized peptide. A compliant report matches the calculated monoisotopic mass of the TB-500 sequence against observed experimental spectra. To learn more about reading analytical documentation, refer to our comprehensive guide on peptide purity HPLC analysis.
Endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria used during peptide expression or handling—present a severe risk to biological research. Even picogram quantities of endotoxin can activate Toll-like receptor 4 (TLR4) in cell cultures, triggering uncharacterized inflammatory cascades that invalidate data regarding cellular migration or cytokine expression.
PX1 Research enforces strict endotoxin screening protocols utilizing quantitative chromogenic LAL assays. Research-grade TB-500 must maintain endotoxin levels below established research thresholds (typically < 0.1 EU/mg to < 1.0 EU/mg depending on assay sensitivity). Laboratories conducting delicate primary cell cultures or animal studies can read our deep dive into endotoxin testing in research peptides to understand biosafety control limits.
In tissue regeneration research, investigators frequently compare TB-500 against other prominent regenerative peptides to analyze synergistic or distinct signaling cascades. While TB-500 operates via G-actin sequestration and endothelial cell motility, BPC-157 influences tissue repair through focal adhesion kinase (FAK) activation, nitric oxide pathway modulation, and VEGFR2 expression. Both compounds are frequently evaluated together in multi-factor soft-tissue models.
A third compound, GHK-Cu, works via copper-chelation dynamics to upregulate gene expression associated with extracellular matrix remodeling and glycosaminoglycan synthesis. When designing comparative studies, laboratories often contrast the cell-migratory effects of TB-500 against the gene-modulating properties of GHK-Cu or the cytoprotective signaling of BPC-157. A complete comparative breakdown is available in our BPC-157 vs TB-500 preclinical review.
Proper handling and reconstitution of TB-500 lyophilized powder are critical to maintaining structural integrity prior to assay execution. Lyophilized vials should be stored at -20°C or -80°C in a desiccated environment to prevent moisture absorption and peptide degradation. Prior to opening, vials must be brought to room temperature to minimize condensation inside the vessel.
Reconstitution should be performed using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the experimental model. The solvent should be gently introduced along the glass wall of the vial rather than sprayed directly onto the peptide cake. Gentle swirling—avoiding violent agitation or vortexing—is recommended to preserve secondary structure. Reconstituted aliquots should be used promptly or flash-frozen at -80°C to prevent degradation from repeated freeze-thaw cycles.
Navigating the research peptide landscape requires rigorous vendor verification. Domestic USA manufacturing and distribution ensure shorter supply chain links, eliminating extended transit times that expose temperature-sensitive peptides to heat degradation. Furthermore, domestic suppliers must adhere to strict quality management systems and standardized analytical practices.
PX1 Research operates out of GMP-compliant facilities located in California and Arizona, providing fast domestic fulfillment and same-day dispatch for orders placed before standard cutoffs. Every lot of all peptides offered by PX1 Research undergoes domestic third-party validation, ensuring that researchers receive fully documented, high-purity compounds backed by verifiable COAs.
High-throughput screening laboratories and academic institutions require consistent batch-to-batch reproducibility across extended research timelines. Variations between peptide lots can introduce unwanted variables, skewing statistical significance in multi-month animal trials or high-volume cellular assays.
To support large-scale preclinical projects, PX1 Research provides dedicated institutional services and wholesale lab accounts. Institutional partners receive batch-reserved inventory, volume-tiered procurement, and direct access to comprehensive analytical packages, ensuring seamless continuity for long-term experimental programs.
What information is included on a PX1 Research TB-500 COA?
Every PX1 Research TB-500 Certificate of Analysis includes the specific lot number, manufacturing date, theoretical vs. observed molecular weight via ESI-MS, RP-HPLC chromatogram showing percentage purity (>99%), and chromogenic LAL endotoxin test results.
Why is third-party COA verification critical for TB-500?
Third-party testing by an accredited ISO 17025 laboratory ensures unbiased verification. It guarantees that the TB-500 powder is free from synthesis failure sequences, residual solvents, or bacterial endotoxins that could distort cell migration or tissue regeneration assays.
How should lyophilized TB-500 be stored upon receipt in the laboratory?
Lyophilized TB-500 should be stored at -20°C for short-to-medium term storage or at -80°C for long-term storage. Vials must be protected from light and moisture exposure.
What solvents are recommended for reconstituting TB-500 for in vitro assays?
TB-500 is readily soluble in sterile Bacteriostatic Water, standard 0.9% Sodium Chloride, or sterile Phosphate-Buffered Saline (PBS). The choice of diluent depends on the specific requirements of the downstream cellular or enzymatic assay.
What is the typical sequence length and molecular weight of TB-500?
TB-500 typically refers to the synthetic active fragment or full-length derivative of Thymosin Beta-4. Depending on the exact construct, the molecular weight ranges from ~889 Da (for short hexapeptide active motifs) up to ~4963 Da for the complete 43-amino-acid chain.
What endotoxin limit is acceptable for TB-500 research compounds?
For sensitive cell culture and in vivo animal research, endotoxin levels should ideally measure below 1.0 EU/mg, with premium analytical grades achieving < 0.1 EU/mg to prevent non-specific immunological activation.
Where does PX1 Research ship its domestic TB-500 orders from?
All PX1 Research products are manufactured and stored in GMP-compliant facilities located in California and Arizona, enabling same-day shipping (M–F) to laboratories across the United States.
Can TB-500 be combined with BPC-157 in preclinical repair protocols?
In preclinical literature, researchers frequently study TB-500 and BPC-157 concurrently to evaluate potential complementary pathways—such as combined G-actin motility (TB-500) and FAK/VEGFR2 signaling (BPC-157) in tendon and muscle injury models.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.